Last edition
News about "Exo-101"
Exogenus Picks Lonza to Develop GMP-Compliant Process to Manufacture Exo-101
Exogenus Therapeutics specializes in the development of healthcare solutions based on extracellular vesicles, including exosomes and other nanotechnologies.
Exo-101 | 12/03/2025 | By Aishwarya | 256
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members